Serotonin 5-HT2A receptor function, psychopathology and cognition in drug-naive first-episode schizofrenia patients
Scientific publications:
Glenthoj BY, Mackeprang T, Svarer C, Rasmussen H, Pinborg LH, Friberg L, Baaré W, Hemmingsen R, Videbaek C.
Frontal dopamine D(2/3) receptor binding in drug-naive first-episode schizophrenic patients correlates with positive psychotic symptoms and gender. Biol Psychiatry. 2006 Sep 15;60(6):621-9

Pinborg LH, Videbaek C, Ziebell M, Mackeprang T, Friberg L, Rasmussen H, Knudsen GM, Glenthoj BY.
123I]epidepride binding to cerebellar dopamine D2/D3 receptors is displaceable: implications for the use of cerebellum as a reference region. Neuroimage. 2007 Feb 15;34(4):1450-3

Erritzoe D, Rasmussen H, Kristiansen KT, Frokjaer VG, Haugbol S, Pinborg L, Baaré W, Svarer C, Madsen J, Lublin H, Knudsen GM, Glenthoj BY.
Cortical and Subcortical 5-HT(2A) Receptor Binding in Neuroleptic-Naive First-Episode Schizophrenic Patients. Neuropsychopharmacology. 2008 Feb 20

Kupers R & Rasmussen H.
Placebo Effects in Pain Trials. In: Wittink H & Carr D. Pain Management: Evidence, Outcomes, and Quality of Life, A Sourcebook. Pain Research and Clinical Management Series. New York: Elsevier 2008

Rasmussen H, Moos Knudsen G, Glenthoj, B.
Visualisering af Skizofreni. In: Best Practice vol 2, 2008.
Available online:
http://www.bestprac.dk/bp_image/Psykiatri-maj.2008_web.pdf